Filing Details
- Accession Number:
- 0001209191-23-054633
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-07 18:09:51
- Reporting Period:
- 2023-11-06
- Accepted Time:
- 2023-11-07 18:09:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534133 | Calcimedica Inc. | CALC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1484729 | Rachel A. Leheny | C/O Calcimedica, Inc. 505 Coast S. Blvd. #202 La Jolla CA 92037 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-06 | 2,440 | $3.12 | 16,840 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,000 | Indirect | By Spouse |
Common Stock | 356,989 | Indirect | By Valence Investments SPV IV, LLC |
Common Stock | 66,228 | Indirect | By Valence Investments SPV V, LLC |
Common Stock | 316,109 | Indirect | By Valence Investments SPV VI, LLC |
Footnotes
- The weighted average purchase price for the transaction reported was $3.1208, and the range of prices were between $3.11 and $3.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.